VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

H.R. 4866 · 116th Congress

National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Passed the House without a recorded vote, then expired. It passed by voice vote or unanimous consent, which don't record how each member voted, but didn't become law before the 116th Congress ended.

2 cosponsors · 1 D, 1 R

1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

  1. House Introduced Oct 28, 2019
  2. House Passed Sep 21, 2020

National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020

What it does: CRS summary · Passed House · Sep 21, 2020

National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020

This bill directs the Food and Drug Administration (FDA) to designate qualified institutions of higher education as National Centers of Excellence in Continuous Pharmaceutical Manufacturing and to provide grants to the centers. Each designated center must conduct research on continuous manufacturing technologies and must share information from such research with the FDA. (Currently, most drug production involves batch manufacturing, which typically takes longer than continuous manufacturing processes.)

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020

Also known as: National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2019

Latest action (Sep 22, 2020): Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Policy area: Health · Origin: House · Introduced: Oct 28, 2019

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

  1. House Introduced Oct 28, 2019
  2. House Passed Sep 21, 2020

No recorded floor vote found.